| | N06 - Psychoanaleptics | This group comprises antidepressants, psychostimulants, nootropics, anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.
|
| | N06B - Psychostimulants, Agents Used for Adhd and Nootropics | Some drugs used in the treatment of narcolepsy are classified here.
Nootropics are classified in N06BX.
Clonidine and guanfacine also used in ADHD are classified in C02AC.
|
| | N06BA - Centrally Acting Sympathomimetics | Amfetamine is classified in this group, see comment under A08AA - Centrally acting antiobesity products.
Combinations of amfetamine and dexamfetamine are classified in N06BA01.
| Since atomoxetine is approved for use both in children, adolescents and in adults, the DDD is based on the treatment of a 70 kg person. The majority of the users will, however, probably be under 18 years of age.
|
| | N06BA09 - Atomoxetine | | Dose | Route of administration | Note |
|---|
| | O | |
|
|
|
